-
2023-507475-21-00
10
2021-01-18
Lung Cancer, Non-Small Cell
-
2024-513730-38-00
5
2021-01-13
Resectable Non-small cell lung cancer
-
2023-507263-19-00
5
2020-12-23
Advanced Non-Small Cell Lung Cancer
-
2023-506911-16-00
5
2020-12-04
ESTROGEN RECEPTOR-POSITIVE, HER2-NEGATIVE LOCALLY ADVANCED OR METASTAT
-
2024-516653-44-00
5
2020-11-30
HER2-Low, Hormone Receptor Positive Breast Cancer which has Progressed
-
2022-502611-10-00
5
2020-11-24
Primary Progressive Multiple Sclerosis (PPMS)
-
2022-502052-30-00
5
2020-10-27
Unresectable Esophageal Squamous Cell Carcinoma
-
2023-510390-33-00
5
2020-10-23
HER2-negative breast cancer patients with high relapse risk after
stan
-
2023-506467-34-00
5
2020-10-20
Relapsing Multiple Sclerosis (MS)
-
2023-506365-64-00
5
2020-10-16
Deleterious Germline or Somatic Homologous Recombination Repair (HRR)
-
2023-506576-27-00
5
2020-09-30
EGFR-mutated locally advanced or metastatic Non Small Cell Lung Cancer
-
2024-514395-40-00
4
2020-08-25
High/intermediate risk hormone receptor (HR) positive/human epidermal
-
2023-505830-89-00
6
2020-08-05
metastatic castrate resistant prostate cancer (mCRPC)
-
2024-515379-36-00
9
2020-08-04
Metastatic pancreatic ductal adenocarcinoma
-
2023-509089-39-00
5
2020-07-01
Non-Muscle Invasive Bladder Cancer
-
2023-505042-25-00
5
2020-05-05
Locally advanced (inoperable) or metastatic HR+/HER2 breast cancer
-
2024-511317-38-00
4
2020-05-04
ALK+ non-small cell lung cancer
-
2024-516532-97-00
9
2020-03-26
Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations
-
2023-508292-37-00
5
2020-03-06
Cardiovascular Disease
-
2022-501012-34-00
5
2020-02-27
Pulmonary Arterial Hypertension
-
2023-509866-39-00
3
2020-02-14
Locally advanced/metastatic breast or non-small cell lung cancer
-
2024-517705-93-00
9
2019-12-13
Histologically or cytologically confirmed diagnosis of extensive or li
-
2022-502354-14-00
5
2019-10-28
Completely resected Stage IIb/c melanoma
-
2024-510776-20-00
5
2019-10-25
Female or male patients with histologically confirmed HR-positive, HER